Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Rehabilitation versus drug therapy for urge urinary incontinence: long-term outcomes.

Kafri R, Shames J, Raz M, Katz-Leurer M.

Int Urogynecol J Pelvic Floor Dysfunct. 2008 Jan;19(1):47-52. Epub 2007 Jun 5.

PMID:
17549429
[PubMed - indexed for MEDLINE]
2.

Rehabilitation vs drug therapy for urge urinary incontinence: short-term outcome.

Kafri R, Langer R, Dvir Z, Katz-Leurer M.

Int Urogynecol J Pelvic Floor Dysfunct. 2007 Apr;18(4):407-11. Epub 2006 Jul 11.

PMID:
16832589
[PubMed - indexed for MEDLINE]
3.

Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan.

D'Souza AO, Smith MJ, Miller LA, Doyle J, Ariely R.

J Manag Care Pharm. 2008 Apr;14(3):291-301.

PMID:
18439051
[PubMed - indexed for MEDLINE]
Free Article
4.

Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial.

Herschorn S, Swift S, Guan Z, Carlsson M, Morrow JD, Brodsky M, Gong J.

BJU Int. 2010 Jan;105(1):58-66. doi: 10.1111/j.1464-410X.2009.09086.x.

PMID:
20132103
[PubMed - indexed for MEDLINE]
5.

Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.

Rogers RG, Bachmann G, Scarpero H, Jumadilova Z, Sun F, Morrow JD, Guan Z, Bavendam T.

Curr Med Res Opin. 2009 Sep;25(9):2159-65. doi: 10.1185/03007990903103279.

PMID:
19601704
[PubMed - indexed for MEDLINE]
6.

Patient-selected goals in overactive bladder: a placebo controlled randomized double-blind trial of transdermal oxybutynin for the treatment of urgency and urge incontinence.

Cartwright R, Srikrishna S, Cardozo L, Robinson D.

BJU Int. 2011 Jan;107(1):70-6. doi: 10.1111/j.1464-410X.2010.09508.x.

PMID:
20626389
[PubMed - indexed for MEDLINE]
7.

Continued symptom improvement in sexually active women with overactive bladder and urgency urinary incontinence treated with tolterodine ER for 6 months.

Rogers RG, Omotosho T, Bachmann G, Sun F, Morrow JD.

Int Urogynecol J Pelvic Floor Dysfunct. 2009 Apr;20(4):381-5. doi: 10.1007/s00192-008-0782-9. Epub 2009 Jan 9.

PMID:
19132285
[PubMed - indexed for MEDLINE]
8.

Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity.

Nitti VW, Rovner ES, Bavendam T.

BJU Int. 2010 May;105(9):1268-75. doi: 10.1111/j.1464-410X.2009.09037.x. Epub 2009 Nov 4.

PMID:
19889062
[PubMed - indexed for MEDLINE]
9.

Anticholinergic drugs, bladder retraining and their combination for urge urinary incontinence: a pilot randomised trial.

Lauti M, Herbison P, Hay-Smith J, Ellis G, Wilson D.

Int Urogynecol J Pelvic Floor Dysfunct. 2008 Nov;19(11):1533-43. doi: 10.1007/s00192-008-0686-8. Epub 2008 Jul 25.

PMID:
18654731
[PubMed - indexed for MEDLINE]
10.

Effectiveness and tolerability of extended-release oxybutynin vs extended-release tolterodine in women with or without prior anticholinergic treatment for overactive bladder.

Anderson RU, MacDiarmid S, Kell S, Barada JH, Serels S, Goldberg RP.

Int Urogynecol J Pelvic Floor Dysfunct. 2006 Sep;17(5):502-11. Epub 2006 May 3.

PMID:
16724169
[PubMed - indexed for MEDLINE]
11.

[Treatment of overactive urinary bladder with imperative urinary incontinence in women].

Neĭmark AI, Riapolova MV, Mel'nik MA.

Urologiia. 2010 Mar-Apr;(2):36-8. Russian.

PMID:
20967993
[PubMed - indexed for MEDLINE]
12.

Electromotive drug-administration: a pilot study for minimal-invasive treatment of therapy-resistant idiopathic detrusor overactivity.

Bach P, Wormland RT, Möhring C, Goepel M.

Neurourol Urodyn. 2009;28(3):209-13. doi: 10.1002/nau.20624.

PMID:
19205067
[PubMed - indexed for MEDLINE]
13.

Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.

Garely AD, Lucente V, Vapnek J, Smith N.

Ann Pharmacother. 2007 Mar;41(3):391-8. Epub 2007 Mar 6.

PMID:
17341526
[PubMed - indexed for MEDLINE]
14.

Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial.

Kaplan SA, Roehrborn CG, Rovner ES, Carlsson M, Bavendam T, Guan Z.

JAMA. 2006 Nov 15;296(19):2319-28. Erratum in: JAMA. 2007 Mar 21:297(11):1195. JAMA. 2007 Oct 24;298(16):1864.

PMID:
17105794
[PubMed - indexed for MEDLINE]
15.

Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community-based, randomized study.

Sand P, Zinner N, Newman D, Lucente V, Dmochowski R, Kelleher C, Dahl NV.

BJU Int. 2007 Apr;99(4):836-44. Epub 2006 Dec 20.

PMID:
17187655
[PubMed - indexed for MEDLINE]
16.

Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study.

Malone-Lee JG, Al-Buheissi S.

BJU Int. 2009 Apr;103(7):931-7. doi: 10.1111/j.1464-410X.2009.08361.x. Epub 2009 Mar 5.

PMID:
19281469
[PubMed - indexed for MEDLINE]
17.

Comparison of fesoterodine and tolterodine in patients with overactive bladder.

Chapple CR, Van Kerrebroeck PE, Jünemann KP, Wang JT, Brodsky M.

BJU Int. 2008 Nov;102(9):1128-32. doi: 10.1111/j.1464-410X.2008.07907.x. Epub 2008 Jul 21.

PMID:
18647298
[PubMed - indexed for MEDLINE]
18.

Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study.

Staskin DR, Dmochowski RR, Sand PK, Macdiarmid SA, Caramelli KE, Thomas H, Hoel G.

J Urol. 2009 Apr;181(4):1764-72. doi: 10.1016/j.juro.2008.11.125. Epub 2009 Feb 23.

PMID:
19233423
[PubMed - indexed for MEDLINE]
19.

Cizolirtine citrate is safe and effective for treating urinary incontinence secondary to overactive bladder: a phase 2 proof-of-concept study.

Zát'ura F, Vsetica J, Abadías M, Pavlík I, Schraml P, Brod'ák M, Villoria J, Sust M; E-4018/CL50 Study Group.

Eur Urol. 2010 Jan;57(1):145-52. doi: 10.1016/j.eururo.2009.04.045. Epub 2009 May 7.

PMID:
19446951
[PubMed - indexed for MEDLINE]
20.

Combined behavioral and individualized drug therapy versus individualized drug therapy alone for urge urinary incontinence in women.

Burgio KL, Goode PS, Richter HE, Markland AD, Johnson TM 2nd, Redden DT.

J Urol. 2010 Aug;184(2):598-603. doi: 10.1016/j.juro.2010.03.141. Epub 2010 Jun 19.

PMID:
20639023
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk